Abstract
For all their high profile, US biotechnology companies in genetics do not yet seem to offer a stable career, because of uncertainties about corporate performance. Meanwhile, attempts are being made to assess the future shape of genetic counselling services, and to attract non-biologists to genome research.

This publication has 0 references indexed in Scilit: